GlassScriptPhysician profile
Natalie Morgan
NPI 1588852594
$8,103.59
in general payments reported to CMS, 2019-2025
31 companies · $1,846 in 2025
The $1,846 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,757 · 2022: $1,589 · 2023: $904 · 2024: $2,008 · 2025: $1,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,366 · Education: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,365.94 |
| Education | $391.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,967.39 | 2021-2025 | |
| Janssen Biotech, INC. | $951.43 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $738.52 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $602.07 | 2021-2025 | |
| Genzyme Corporation | $438.36 | 2021-2025 | |
| Ucb, INC. | $409.34 | 2021-2025 | Bimzelx |
| Incyte Corporation | $372.02 | 2021-2024 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $366.31 | 2022-2025 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $336.61 | 2022-2025 | Dupixent |
| Pfizer INC. | $311.05 | 2021-2025 | |
| Lilly USA, LLC | $273.88 | 2021-2025 | Taltz, Ebglyss |
| Organon LLC | $210.39 | 2025 | Vtama |
| Leo Pharma INC. | $203.67 | 2021-2025 | Adbry, Anzupgo |
| Vyne Pharmaceuticals INC. | $162.66 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $88.41 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $73.41 | 2021-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Amgen INC. | $70.23 | 2021-2023 | Otezla |
| Organogenesis INC. | $69.19 | 2022-2024 | Novachor, Puraply Wound Matrix |
| Sanofi-Aventis U.S. LLC | $64.95 | 2021 | |
| Arcutis Biotherapeutics, INC. | $63.85 | 2023-2025 | Zoryve |
| Galderma Laboratories, L.P. | $61.02 | 2021-2025 | Nemluvio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.47 | 2023-2024 | Spevigo, Cyltezo |
| Kerecis Limited | $46.48 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Medimetriks Pharmaceuticals, INC. | $28.25 | 2022 | |
| Kyowa Kirin, INC. | $28.23 | 2024 | Poteligeo |
| Mayne Pharma Commercial LLC | $27.42 | 2021 | |
| Misonix INC | $22.81 | 2021 | |
| Verrica Pharmaceuticals INC. | $22.20 | 2024 | Ycanth |
| Paratek Pharmaceuticals, INC. | $16.54 | 2025 | Nuzyra |
| Dermavant Sciences, INC. | $14.44 | 2024 | Vtama |
| Nabriva Therapeutics, Plc | $13.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.